Alcohol
Volume 25, Issue 2 , Pages 99-105 , October 2001

Effect of ursodeoxycholic acid on prostaglandin metabolism and microsomal membranes in alcoholic fatty liver

  • Oxana Ya. Lukivskaya

      Affiliations

    • Institute of Biochemistry, National Academy of Sciences, 230017 Grodno, Belarus
    • ,
  • Alexandr A. Maskevich

      Affiliations

    • Department of Spectroscopy, Grodno State University, 230001 Grodno, Belarus
    • ,
  • Vyacheslav U. Buko

      Affiliations

    • Institute of Biochemistry, National Academy of Sciences, 230017 Grodno, Belarus
    • Corresponding Author InformationCorresponding author. Department of Experimental Hepatology, Institute of Biochemistry, National Academy of Sciences, BLK-50, 230017 Grodno, Belarus. Tel.: +375-152-338411; fax: +375-152-338411

Received 13 March 2001 ,Revised 21 May 2001 ,Accepted 25 June 2001.

References 

  1. Albano E, Tomasi A, Persson J-O, Terelius Y, Goria-Gatti L, Ingelman-Sundberg M, et al. Role of ethanol-inducible cytochrome P450 P450IIE1 in catalysing the free radical activation of aliphatic alcohols. Biochem Pharmacol. 1991;41:1895–1902
  2. Bartlett GR. Colorimetric assay method for free and phosphorilated glyceric acid. J Biol Chem. 1959;234:466–471
  3. Bellantani S, Chao YC, Ferretti I, Panini R, Tiribelli C. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats. Biochem Biophys Res Commun. 1996;220:479–483
  4. Bieri JG, Stoewsand GS, Briggs GM. Report of the American Institute of Nutrition Ad Hoc Committee on standards for nutritional studies. J Nutr. 1977;107:1340–1348
  5. Buko VU. Molecular mechanisms of hepatoprotective action of prostaglandins in alcoholic liver injury. Z Gastroenter. 1991;29(suppl. 2):49–53
  6. Buko VU, Artsukevich A, Lukivskaya O, Zavodnik L, Ignatenko K, Sadovnichy V, et al. Antiradical and antioxidative properties of compounds having the steroid structure. Curr Top Biophys. 1998;22(suppl. 2):33–39
  7. Buko VU, Sadovnichy VV. Cytochrome P-450 and free radical generation in rat liver microsomes under the influence of prostaglandin E1. Biochem Mol Biol Int. 1996;39:1177–1184
  8. Buko VU, Sushko LI. Role of microsomal ethanol-oxidizing system in regulation of linoleoyl-CoA desaturase activity after long-term ethanol administration. Alcohol Alcohol. 1988;23:69–71
  9. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology. 1990;11:12–15
  10. Cunningham CC, Coleman WB, Spach PI. The effects of chronic ethanol consumption on hepatic mitochondrial energy metabolism. Alcohol Alcohol. 1990;25:127–136
  11. de Gomez Dumm INT, de Alaniz MJT, Brenner RR. Effect of epinephrine on the oxidative desaturation of fatty acids in the rat. J Lipid Res. 1976;17:616–621
  12. Dlugosz JW, Korsten MA, Lieber CS. The effect of the prostaglandin analogue misoprostol on rat liver mitochondria after chronic alcohol feeding. Life Sci. 1991;49:969–978
  13. Folch JB, Lees M, Sloane-Stanley GN. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem. 1957;226:497–509
  14. Galla H-J, Sackmann E. Lateral diffusion in the hydrophobic region of membranes: use of pyrene excimers as optical probes. Biochim Biophys Acta. 1974;339:103–115
  15. Güldutuna S, Zimmer G, Imhof M, Bhatti S, You T, Leuschner U. Molecular aspects of membrane stabilization by ursodeoxycholate. Gastroenterology. 1993;104:1736–1744
  16. Hagne T-A. Effects of unsaturated fatty acids on cell membrane functions. Scand J Clin Lab Invest. 1988;48:381–388
  17. Haynes DR, Whitehouse MW, Vernon-Roberts B. The prostaglandin E1 analogue, misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology. 1992;76:251–257
  18. James OFW. Ursodeoxycholic acid treatment for chronic cholestatic liver disease. J Hepatol. 1990;11:5–8
  19. Jaquemin E, Dumont M, Mallet A, Erlinger S. Ursodeoxycholic acid improves ethinyl estradiol–induced cholestasis in rat. Eur J Clin Invest. 1993;23:794–802
  20. Lee H, Hosein EA. Chronic alcohol feeding and its withdrawal on the structure and function of the rat liver plasma membrane: a study with 125I-labelled glucagon binding as a metabolic probe. Can J Physiol Pharmacol. 1982;60:1171–1176
  21. Leuschner U, Güldutuna S, Bhatti S, Sipos T, You T, Zimmer G. Cytoprotection by ursodeoxycholic acid. In:  Van Berge Henegouven GP,  Van Hoek B,  De Groote J,  Matern S editor. Cholestatic Liver Diseases: New Strategies for Prevention and Treatment of Hepatobiliary and Cholestatic Liver Diseases. Dordrecht/Boston/London: Kluwer Academic Press; 1994;p. 218–225
  22. Lieber CS, DeCarli LM. Quantitative relationship between amount of dietary fat and severity of alcoholic fatty liver. Am J Clin Nutr. 1970;23:474–478
  23. Lindros KO. Alcoholic liver disease: pathobiological aspects. J Hepatol. 1995;23(Suppl. 1):7–15
  24. Ljubuncic P, Tanne Z, Bomzon A. Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease. Dig Dis Sci. 2000;45:1921–1928
  25. Marco C, Ceacero F, Garcia-Peregrin E, Segovia JL. Ethanol sensitivity and fatty acid composition of chick liver mitochondrial and microsomal membranes. Biochem Int. 1985;11:291–299
  26. Marnett LJ, Kennedy TA. Comparison of the peroxidase activity of hemoproteins and cytochrome P-450. In:  Oritz de Montellano PR editors. Cytochrome P-450: Structure, Mechanism and Biochemistry. New York and London: Plenum Press; 1995;p. 49–82
  27. Maxwell WJ, Keating JJ, Hogan FP, Kennedy NP, Keeling PWN. Prostaglandin E2 and leukotriene B4 synthesis by peripheral leucocytes in alcoholics. Gut. 1989;30:1270–1274
  28. Nanji AA, Zakim D. Alcoholic liver disease. In:  Boyer TD,  Zakim D editor. Hepatology: A Textbook of Liver Disease. Vol. 2:Philadelphia: Saunders; 1996;p. 891–961
  29. Nanji AA, Zhao S, Sadrzadeh SMN, Waxman DJ. Use of reverse transcription-polymerase chain reaction to evaluate in-vivo cytokine gene expression in rats fed ethanol for long periods. Hepatology. 1994;19:1483–1487
  30. Neuman MG, Cameron RG, Shear NH, Bellentani S, Tiribelli C. Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line. Gastroenterology. 1995;109:555–563
  31. Neuman MG, Shear NH, Bellentani S, Tiribelli C. Role of cytokines in ethanol-induced cytotoxicity in vitro in Hep G2 cells. Gastroenterology. 1998;115:157–166
  32. Nordmann R, Ribiere C, Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic Biol Med. 1992;12:219–240
  33. Oliva L, Beauge F, Choquart D, Montet A-M, Guitaoui M, Montet J-C. Ursodeoxycholate alleviates alcoholic fatty liver damage in rats. Alcohol Clin Exp Res. 1998;22:1538–1543
  34. Plevris JN, Hayes PC, Bouchier AD. Ursodeoxycholic acid in the treatment of alcoholic liver disease. Eur J Gastroenterol Hepatol. 1991;3:653–656
  35. Poupon R. Management of primary billiary cirrhosis resistant to ursodeoxycholic acid therapy. J Hepatol. 2000;32(Suppl. 2):19–20
  36. Reitz RC. Relationship of the acyl-CoA desaturases to certain membrane fatty acids changes induced by ethanol consumption. Proc West Pharmacol Soc. 1984;27:247–279
  37. Simko V, Michael S. Effect of ursodeoxycholic acid on in vivo and in vitro toxic liver injury in rats. Aliment Pharmacol Ther. 1994;8:315–322
  38. Simpson KJ. Pathogenesis of alcoholic hepatic steatosis. Addict Biol. 1996;1:363–370
  39. Sugawara Y, Kubota K, Ogura T, Esumi H, Inoue K, Takayama T, et al. Protective effect of prostaglandin E1 against ischemia/reperfusion–induced liver injury: results of a prospective, randomized study in cirrhotic patients undergoing subsegmentectomy. J Hepatol. 1998;29:969–976
  40. Tabouy L, Zamora AJ, Oliva L, Montet A-M, Beauge F, Montet J-C. Ursodeoxycholate protects against ethanol-induced liver mitochondrial injury. Life Sci. 1998;63:2259–2270
  41. Tai HH. Mechanism of prostaglandin biosynthesis in rabbit kidney medulla. A rate- limiting step and the differential stimulatory actions of ladrenaline and glutathione. Biochem J. 1976;160:577–581
  42. Vessey DA, Zakim D. Characterization of the reaction of GDP-mannose with dolichol phosphate in liver membranes. Eur J Biochem. 1975;53:499–504

PII: S0741-8329(01)00171-9

Alcohol
Volume 25, Issue 2 , Pages 99-105 , October 2001

Article Tools